SPP1 and cancer: Binding of CD44v6 to OPN is dependent on β1 integrin but independent of RGD-motif to promote cell motility and chemotaxis [63], thus combination of β1 integrin and CD44v6 mAbs would be an attractive strategy on cancer treatment.